Kits Eyecare (TSE:KITS) has released an update.
KITS Eyecare Ltd. announced a significant growth in its second quarter of 2024, with a 26% increase in revenue to $37.9 million and a notable rise in Canadian revenue by 47%. The company also marked its seventh consecutive quarter with positive adjusted EBITDA, highlighting operational efficiency and a strong financial performance.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.
